(c) 2024 PillSync.com

haloperidol 1 mg

INDICATIONS AND USAGE Haloperidol is indicated for use in the management of manifestations of psychotic disorders. Haloperidol is indicated for the control of tics and vocal utterances of Tourette’s Disorder in children and adults. Haloperidol is effective for the treatment of severe behavior problems in children of combative, explosive hyperexcitability (which cannot be accounted for by immediate provocation). Haloperidol is also effective in the short-term treatment of hyperactive children who show excessive motor activity with accompanying conduct disorders consisting of some or all of the following symptoms: impulsivity, difficulty sustaining attention, aggressivity, mood lability, and poor frustration tolerance. Haloperidol should be reserved for these two groups of children only after failure to respond to psychotherapy or medications other than antipsychotics.

Zydus Pharmaceuticals USA Inc.


2 weeks ago ROUND YELLOW 15 12 haloperidol 1 mg

ROUND YELLOW 15 12

2 weeks ago ROUND YELLOW 15 12 haloperidol 1 mg

15 12 ROUND YELLOW

HOW SUPPLIED

HALOPERIDOL Tablets USP, 0.5 mg are white to off white coloured, round, flat faced, bevel edged, uncoated tablets debossed with "15" and "11" on either side of partial score line and plain on other side and are supplied as follows: NDC 68382-407-01 in bottles of 100 tablets NDC 68382-407-10 in bottles of 1,000 tablets NDC 68382-407-77 in carton of 100 tablets (10 x 10 unit-dose)

HALOPERIDOL Tablets USP, 1 mg are pale yellow to yellow coloured, round, flat faced, bevel edged, uncoated tablets debossed with "15" and "12" on either side of partial score line and plain on other side and are supplied as follows: NDC 68382-408-01 in bottles of 100 tablets NDC 68382-408-10 in bottles of 1,000 tablets NDC 68382-408-77 in carton of 100 tablets (10 x 10 unit-dose)

HALOPERIDOL Tablets USP, 2 mg are light pink coloured, round, flat faced, bevel edged, uncoated tablets debossed with "15" and "13" on either side of partial score line and plain on other side and are supplied as follows: NDC 68382-409-01 in bottles of 100 tablets NDC 68382-409-10 in bottles of 1,000 tablets NDC 68382-409-77 in carton of 100 tablets (10 x 10 unit-dose)

HALOPERIDOL Tablets USP, 5 mg are green, capsule-shaped, flat-faced, beveled-edge tablets debossed with the logo of 'ZC', '07' and partial bisect, on one side and plain on the other side and are supplied as follows: NDC 68382-079-01 in bottles of 100 tablets NDC 68382-079-10 in bottles of 1,000 tablets

HALOPERIDOL Tablets USP, 10 mg are light green, capsule-shaped, flat-faced, beveled-edge tablets debossed with the logo of 'ZC', '08' and partial bisect, on one side and plain on the other side and are supplied as follows: NDC 68382-080-06 in bottles of 30 tablets NDC 68382-080-01 in bottles of 100 tablets NDC 68382-080-10 in bottles of 1,000 tablets

HALOPERIDOL Tablets USP, 20 mg are coral, capsule-shaped, flat-faced, beveled-edge tablets debossed with the logo of 'ZC', '09' and bisect on one side and plain on the other side and are supplied as follows: NDC 68382-081-06 in bottles of 30 tablets NDC 68382-081-01 in bottles of 100 tablets Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


More pills like ROUND 15 12












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site